Electromedical Technologies, Inc financial data

Symbol
EMED on OTC
Industry
Surgical & Medical Instruments & Apparatus
Location
16561 N 92 Nd Street, Suite 101, Scottsdale, AZ
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 12.5 % -63.8%
Quick Ratio 1.93 % -53.2%
Debt-to-equity -124 % +28.7%
Return On Equity 42.7 % -79.1%
Return On Assets -179 % +35.2%
Operating Margin -72.2 % +54.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 566M shares
Common Stock, Shares, Outstanding 566M shares +30.9%
Entity Public Float 1.33M USD 0%
Common Stock, Value, Issued 5.66K USD +30.9%
Weighted Average Number of Shares Outstanding, Basic 567M shares +69.2%
Weighted Average Number of Shares Outstanding, Diluted 1.94B shares +479%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 1.2M USD -12.6%
Cost of Revenue 290K USD -2.72%
Operating Income (Loss) -869K USD +60.5%
Net Income (Loss) Attributable to Parent -1.33M USD +64.1%
Earnings Per Share, Basic 0 USD/shares
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 117K USD -71.9%
Accounts Receivable, after Allowance for Credit Loss, Current 4.34K USD -83.2%
Inventory, Net 31.7K USD -72%
Assets, Current 389K USD -55.9%
Property, Plant and Equipment, Net 150K USD 0%
Operating Lease, Right-of-Use Asset 126K USD
Assets 665K USD -35.5%
Accounts Payable, Current 240K USD -10.8%
Accrued Liabilities, Current 38.5K USD -80.2%
Contract with Customer, Liability, Current 438K USD +84.4%
Liabilities, Current 3.83M USD +21.5%
Other Liabilities, Noncurrent 4.98K USD -50.2%
Liabilities 4.06M USD +22.7%
Retained Earnings (Accumulated Deficit) -28.1M USD -4.98%
Stockholders' Equity Attributable to Parent -3.4M USD -49%
Liabilities and Equity 665K USD -35.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -158K USD +65%
Net Cash Provided by (Used in) Financing Activities 150K USD
Net Cash Provided by (Used in) Investing Activities 1.89M USD
Common Stock, Shares Authorized 5B shares +150%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -8.86K USD -101%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 117K USD -71.9%
Interest Paid, Excluding Capitalized Interest, Operating Activities 23.2K USD +1.28%
Deferred Tax Assets, Gross 1.26M USD +35%
Operating Lease, Liability 132K USD
Lessee, Operating Lease, Liability, to be Paid 152K USD
Property, Plant and Equipment, Gross 175K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Two 68.2K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 66.2K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 20.1K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 17.2K USD
Additional Paid in Capital 23.9M USD +0.89%
Depreciation, Depletion and Amortization 0 USD -100%
Share-based Payment Arrangement, Expense -4.7K USD -118%
Interest Expense 338K USD -69.6%